MeSH tree: D20.215.894.200
Pancreatic cancer has a five-year survival rate of just 13%, making it the deadliest cancer, according to the American Cancer Society. It typically causes no symptoms until it has already metastasized. Surgery, radiation ...
Jun 11, 2025
0
27
WEHI scientists have uncovered a promising new way to enhance the effectiveness of vaccines by tapping into the potential of a specific type of immune cell, opening the door to long-lasting vaccines for viruses and enhanced ...
May 7, 2025
0
76
The U.S. Health and Human Services Department says it will require placebo testing of "all new vaccines," raising questions about the rollout of updated COVID-19 vaccines and other vaccines.
May 2, 2025
0
28
On 12 March 2020, Norway recorded its first death from COVID-19.
Apr 29, 2025
0
17
Our body's own defense system not only clears away bacteria and viruses, it can also fight cancer. However, not all tumor cells are easily recognizable by the immune system. In addition, they are constantly changing and camouflaging ...
Apr 24, 2025
0
35
Federal cuts to funding could "decimate" medical research in the United States, delaying cures and costing countless lives, according to a leader in cancer research.
Apr 8, 2025
0
10
UK oncology researchers have come together to write the first-ever national thought leadership strategy report into cancer vaccine advances and the opportunities these present for those affected by cancer. The strategy report ...
Jan 21, 2025
0
23
A cancer vaccine that had little success in clinical trials for patients with advanced tumors could potentially have efficacy if administered earlier in the treatment cycle, according to a study from Vanderbilt researchers.
Oct 7, 2024
0
95
A collaboration between four MIT groups, led by principal investigators Laura L. Kiessling, Jeremiah A. Johnson, Alex K. Shalek, and Darrell J. Irvine, in conjunction with a group at Georgia Tech led by M.G. Finn, has revealed ...
Sep 16, 2024
0
69
By recruiting the immune system to combat tumor cells, immunotherapy has improved survival rates, offering hope to millions of cancer patients. However, only about one in five people responds favorably to these treatments.
Aug 6, 2024
0
63
